Company

Perrigo Company plc

Headquarters: Dublin, Ireland

Founded: 1887

Employees: 9,900

CEO: Mr. Murray S. Kessler

NYSE: PRGO +2.26%

Market Cap

$4.55 Billion

USD as of Jan. 1, 2024

Market Cap History

Perrigo Company plc market capitalization over time

Evolution of Perrigo Company plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Perrigo Company plc

Detailed Description

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Perrigo Company plc has the following listings and related stock indices.


Stock: NYSE: PRGO wb_incandescent

Stock: FSX: PIG wb_incandescent

Product & Services

OTC, RX, API, Medical Diagnostic, pharmaceuticals

Key People

Murray S. Kessler, President and CEO, Board Member

Financials

Revenue: US$3.54 billion (2013)

Operating income: US$805 million (2013)

Net income: US$530 million (2013)

Details

Headquarters:

The Sharp Building

Hogan Place

Dublin, 2

Ireland

Phone: 353 1 709 4000